Welcome visit 4th Floor, Pharma Area, GoldenBiotech Booth S 931.
Golden Biotechnology Corp.,leading pharma in cancer ,oncology and other new drugs . Received Orphan Drug Designations by US FDA for Pancreatic Cancer, AML and HCC and Pancreatic Cancer by EU EMA. Completed Phase II trial of NSCLC Lung Cancer and released brilliant results in 2019 ASCO meeting.Winner of the Advance Queensland - Johnson & Johnson Innovation QuickFire Challenge in Alzheimer's Disease study in 2016. In 2018 , successful unblinding on clinical trial of hyperlipidemia. Welcome visit us at Booth S931 Biotech .Welcome for opportunities in invest and new drug development cooperation.&Pharmaceuticals Area.
1. Golden Biotechnology Corp.'s latest developments and clinical progress of new drug Antroquinonol® in Non-small Cell Lung Cancer(NSCLC), Pancreatic Cancer, Liver Cancer(HCC), Hyperlipidemia, Atopic Dermatitis, Hepatitis B, Alzheimer's disease, Non alcoholic Steatohepatitis(NASH) and AML.
Cooperation projects and needs
1. Welcome cooperation in new drugs development, invest and licensing....( Oncology ,Cancer drug,non-oncology)
2. Welcome cooperation in health supplement products distribution cooperation...(functional food, nutrient supplement...)